Marico's board approved its Q1 consolidated financial results for the quarter ended June 30, 2025. Net Profit rose to Rs 513 Cr, up from Rs 474 Cr in the same quarter last year. Revenue from operations increased to Rs 3,259 Cr from Rs 2,643 Cr. The company's EPS stands at Rs 3.90, compared to Rs 3.60 previously. Additionally, Marico boosted its stake in Plix (Satiya Nutraceuticals) to 60% by acquiring an additional 8.8% from existing investors, signaling continued strategic investments.